Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder Cancer

Mediators of Inflammation - Egypt
doi 10.1155/2012/528690
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Molecular Biomarkers to Predict Response to Neoadjuvant Chemotherapy for Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2017English

Β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer.

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

EZH2 in Bladder Cancer, a Promising Therapeutic Target

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2015English

Hormone Signaling Pathways as Treatment Targets in Renal Cell Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2016English

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment

Current Rheumatology Reviews
Rheumatology
2015English

Mitochondria as Targets of Chemotherapy

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2012English

ERCC1 as a Biomarker for Bladder Cancer Patients Likely to Benefit From Adjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Amplification of 7p12 Is Associated With Pathologic Non-Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy